System zur Abgabe einer Tobramycin-Formulierung

Patent europeic · EP1320355 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1320355
Numer da la dumonda
EP02771857
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
17-05-2002
Publitgà
25-06-2003
Concedì
05-04-2006
Stritgà
05-04-2006
Motiv
Revocà en la procedura d’opposiziun
Classas IPC
A61K 9/00 (2006.01)
A61K 9/12 (2006.01)
A61K 31/7036 (2006.01)
Prioritad
US 292234 P 18.05.2001
Dumonda PCT
PCT/US2002/015999 17.05.2002
Publicaziun PCT
WO2002/094217 28.11.2002
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-06-2024

    Midada

    Published in Swissreg on 25.06.2024

  2. 09-07-2010

    Midada

    Published in Swissreg on 09.07.2010

  3. 29-02-2008

    Adressa midada

    Owner
    CHIRON CORPORATION, 4560 Horton Street, Emeryville, California 94608-2916, USA → NOVARTIS VACCINES & DIAGNOSTICS, INC., 4560 Horton Street, Emeryville, CA 94608-2916, USA

    Published in +pat+ No 4 in 2008

  4. 31-07-2006

    Represchentant inscrit

    Representative
    Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich

    Published in +pat+ No 14 in 2006

  5. 13-04-2006

    Concedì

    Published in +pat+ No 7 in 2006

Partidas

Inventur

SPEIRS, Robert, J.

Lynwood, WA 98037, US

SCHAEFFLER, Barbara, A.

Seattle, WA 98103, US

CHALLONER, Peter, B.

Seattle, WA 98109, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.